Boston, MANCT04440280Now EnrollingIRB Ready

Fuchs Endothelial Corneal Dystrophy Clinical Trial in Boston, MA

Access cutting-edge fuchs endothelial corneal dystrophy treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.

Sponsored by Massachusetts Eye and Ear Infirmary

Quick Self-Assessment

See if you qualify for this Boston location

Preparing your pre-screening questions…

Expert Care in Boston

Access fuchs endothelial corneal dystrophy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related fuchs endothelial corneal dystrophy treatment provided free

Apply for This Boston Location

Check if you qualify for this fuchs endothelial corneal dystrophy clinical trial in Boston, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Boston

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Boston site if eligible
  4. 4Begin participation

About This Fuchs Endothelial Corneal Dystrophy Study in Boston

This protocol will investigate whether topical application of N-acetyl cysteine (NAC) eye drops decreases oxidative stress and confers cytoprotection in patients with FECD.

Sponsor: Massachusetts Eye and Ear Infirmary

Who Can Participate

Inclusion Criteria

Male or female ≥21 years of age at time of surgical evaluation.
Diagnosis of advanced FECD and visually significant cataract
Indication for DMEK (Descemet Membrane Endothelial Keratoplasty) with concurrent cataract surgery
Written informed consent obtained from subject and ability for subject to comply with the requirements of the study.
Willingness and ability to adhere to medication regimen

Exclusion Criteria

Pregnant, breastfeeding, or unwilling to practice birth control during participation in the study.
History of prior intraocular surgery in study eye including cataract, glaucoma and/or retina surgery
History of other corneal diseases, such as severe dry eye, corneal scars, pseudophakic bullous keratopathy, corneal degenerations, corneal infections
Use of ocular prescription medications except for lubricants, hyperosmotic agents, or ocular hypotensive agents
History of ocular surface infection within the past 30 days
Use of systemic, inhalational, or topical N-Acetylcysteine within the past 30 days
History of intolerance to topical N-Acetylcysteine
Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data. \-

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Boston?

Yes, this clinical trial (NCT04440280) has an active research site in Boston, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Fuchs Endothelial Corneal Dystrophy Treatment Options in Boston, MA

If you're searching for fuchs endothelial corneal dystrophy treatment options in Boston, MA, this clinical trial (NCT04440280) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced fuchs endothelial corneal dystrophy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all fuchs endothelial corneal dystrophy clinical trials near you to find additional studies recruiting in your area.

More Ulcerative Colitis Trials in Boston, MA

See all ulcerative colitis clinical trials recruiting in Boston — not just this study.

Browse Ulcerative Colitis Trials in Boston →

Browse More Trials by Condition

Ulcerative Colitis TrialsPulmonary Hypertension TrialsHidradenitis Suppurativa TrialsAll Conditions →

Ready to Join in Boston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Boston, MA